Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Hogan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2001
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tractS Cu-Uvin, J W Hogan, A M Caliendo, et al.
Obstetrics and Gynecology|July 1, 1997
Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesG N Frishman, J A Canick, J W Hogan, et al.
Fertility and Sterility|March 1, 1997
The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilizationA S Blazar, J W Hogan, D B Seifer, et al.
Fertility and Sterility|January 1, 1997
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcomeD B Seifer, G Lambert-Messerlian, J W Hogan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her studyV E Stone, J W Hogan, P Schuman, et al.
Obstetrics and Gynecology|February 16, 2000
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnanciesM G Phipps, J W Hogan, J F Peipert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2001
A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor useK T Tashima, J W Hogan, L I Gardner, et al.
Gynecologic Oncology|December 31, 1997
S-Phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancerM E Gordinier, M M Steinhoff, J W Hogan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study GroupS Cu-Uvin, J W Hogan, D Warren, et al.
Microbiology Spectrum|November 29, 2022
Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug ResistanceV Novitsky, W Nyandiko, R Vreeman, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2001
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tractS Cu-Uvin, J W Hogan, A M Caliendo, et al.
Obstetrics and Gynecology|July 1, 1997
Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesG N Frishman, J A Canick, J W Hogan, et al.
Fertility and Sterility|March 1, 1997
The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilizationA S Blazar, J W Hogan, D B Seifer, et al.
Fertility and Sterility|January 1, 1997
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcomeD B Seifer, G Lambert-Messerlian, J W Hogan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her studyV E Stone, J W Hogan, P Schuman, et al.
Obstetrics and Gynecology|February 16, 2000
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnanciesM G Phipps, J W Hogan, J F Peipert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2001
A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor useK T Tashima, J W Hogan, L I Gardner, et al.
Gynecologic Oncology|December 31, 1997
S-Phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancerM E Gordinier, M M Steinhoff, J W Hogan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study GroupS Cu-Uvin, J W Hogan, D Warren, et al.
Microbiology Spectrum|November 29, 2022
Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug ResistanceV Novitsky, W Nyandiko, R Vreeman, et al.
Pageof 4